The story of Viagra, and its creator copyright, presents a intriguing case study for investors. Originally a blockbuster drug, yielding billions in sales , its intellectual property lapse created a flood of lower-priced alternatives , significantly diminishing its dominance. While some pharmaceutical companies may seek to capitalize on similar cond